We are live on ! Find out more
MMH

Menora Mivtachim Holdings Portfolio holdings

AUM $21.1B
1-Year Est. Return 40.03%
This Fund
S&P 500
This Quarter Est. Return
+6.45%
1 Year Est. Return
+40.03%
3 Year Est. Return
+110.3%
5 Year Est. Return
+129.3%
10 Year Est. Return
+734.74%
AUM
$1.95B
AUM Growth
+$130M
Cap. Flow
+$31.4M
Cap. Flow %
1.61%
Top 10 Hldgs %
46.02%
Holding
118
New
37
Increased
20
Reduced
27
Closed
7

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$42.7M
2
PM icon
Philip Morris
PM
+$19.9M
3
MDT icon
Medtronic
MDT
+$17.5M
4
AMZN icon
Amazon
AMZN
+$13.4M
5
KITE
Kite Pharma, Inc.
KITE
+$12.3M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$56.9M
2
PRGO icon
Perrigo
PRGO
+$26.7M
3
BAC icon
Bank of America
BAC
+$25.3M
4
WFC icon
Wells Fargo
WFC
+$22.2M
5
C icon
Citigroup
C
+$17.4M

Sector Composition

Rank Sector Weight
1 Financials 22.44%
2 Communication Services 19.81%
3 Healthcare 19.5%
4 Industrials 11.57%
5 Technology 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
26
ExxonMobil
XOM
$634B
$27.1M 1.39%
299,920
+10,350
+4% +$904K
SPLS
27
DELISTED
Staples Inc
SPLS
$26.1M 1.34%
2,879,750
– –
HD icon
28
Home Depot
HD
$355B
$25.7M 1.32%
191,660
-49
-0% -$6.32K
AMZN icon
29
Amazon
AMZN
$2.96T
$25.2M 1.29%
671,000
+341,000
+103% +$13.4M
GS icon
30
Goldman Sachs
GS
$303B
$24.4M 1.25%
101,888
-670
-0.7% -$136K
MLNX
31
DELISTED
Mellanox Technologies, Ltd.
MLNX
$24.1M 1.24%
590,105
+98,600
+20% +$4.17M
ORCL icon
32
Oracle
ORCL
$423B
$21.8M 1.12%
567,490
+135,100
+31% +$5.28M
PFE icon
33
Pfizer
PFE
$153B
$21.4M 1.1%
693,460
-131,329
-16% -$4.01M
JNJ icon
34
Johnson & Johnson
JNJ
$625B
$20.9M 1.07%
181,300
– –
AGN
35
DELISTED
Allergan plc
AGN
$19.7M 1.01%
94,010
+3,430
+4% +$711K
PM icon
36
Philip Morris
PM
$295B
$19.7M 1.01%
+215,000
New +$19.9M
SODA
37
DELISTED
SodaStream International Ltd
SODA
$19.4M 1%
491,836
– –
MDT icon
38
Medtronic
MDT
$112B
$15.9M 0.81%
+223,000
New +$17.5M
AMGN icon
39
Amgen
AMGN
$222B
$15.4M 0.79%
105,270
– –
FOMX
40
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$15M 0.77%
1,350,847
– –
NDRM
41
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$12.8M 0.66%
577,974
-12,750
-2% -$239K
PANW icon
42
Palo Alto Networks
PANW
$297B
$12.8M 0.65%
612,000
+120,000
+24% +$2.88M
TSEM icon
43
Tower Semiconductor
TSEM
$28.5B
$12.2M 0.63%
642,098
– –
ACM icon
44
Aecom
ACM
$9.75B
$10.8M 0.56%
+298,000
New +$9.89M
SEDG icon
45
SolarEdge
SEDG
$1.95B
$10.6M 0.54%
852,000
+439,500
+107% +$6.1M
MSFT icon
46
Microsoft
MSFT
$3.71T
$10M 0.51%
+161,500
New +$9.71M
FLR icon
47
Fluor
FLR
$7.96B
$9.98M 0.51%
+190,000
New +$9.87M
SWFT
48
DELISTED
Swift Transportation Company
SWFT
$9.68M 0.5%
+397,500
New +$9.28M
J icon
49
Jacobs Solutions
J
$17B
$9.44M 0.48%
+200,205
New +$9.22M
NVMI
50
Nova
NVMI
$12.5B
$7.89M 0.4%
599,784
– –
1
2
3 4 5

Similar funds

Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Menora Mivtachim Holdings's Q4 2016 Portfolio in Review

As of Q4 2016, Menora Mivtachim Holdings held 118 positions worth $1.95B, up 7.2% from $1.82B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Menora Mivtachim Holdings's Q4 2016 filing shows 37 new, 20 increased, 27 reduced and 7 closed positions. Its largest new stake was Philip Morris: 215,000 shares worth $19.7M. The largest sale was JPMorgan Chase, an estimated $56.9M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 25% a quarter earlier, followed by Communication Services and Healthcare.

  • Menora Mivtachim Holdings's largest Q4 2016 buy was Philip Morris: 215,000 shares worth $19.7M.
  • Menora Mivtachim Holdings added most to Teva Pharmaceuticals in Q4 2016, an estimated $42.7M increase.
  • Menora Mivtachim Holdings's biggest Q4 2016 reduction was JPMorgan Chase, cutting an estimated $56.9M.
  • Menora Mivtachim Holdings fully exited PepsiCo in Q4 2016, selling an estimated $1.43M.
  • Menora Mivtachim Holdings's ten largest holdings make up 46% of its $1.95B portfolio in Q4 2016.
  • Menora Mivtachim Holdings opened 37 new positions and closed 7 in Q4 2016.
  • Menora Mivtachim Holdings's portfolio value rose 7.2% quarter-over-quarter to $1.95B.

Based on Menora Mivtachim Holdings's 13F filing for Q4 2016, filed 15 Feb 2017.